2,792
Views
45
CrossRef citations to date
0
Altmetric
Research Article

A class of sulfonamides as carbonic anhydrase I and II inhibitors

, , &
Pages 180-188 | Received 20 Mar 2016, Accepted 01 Jun 2016, Published online: 29 Jun 2016
 

Abstract

Four groups of novel sulfonamide derivatives: (i) acetoxybenzamide, (ii) triacetoxybenzamide, (iii) hydroxybenzamide and (iv) trihydroxybenzamide, all having thiazole, pyrimidine, pyridine, isoxazole and thiadiazole moieties were prepared and their inhibitory effects were studied on two metalloenzymes, i.e. carbonic anhydrase isozymes (hCA I and II), purified from human erythrocyte cells by Sepharose-4B-l-tyrosine-sulfanilamide affinity chromatography. These enzymes are present in almost all living organisms to catalyse the synthesis of bicarbonate ion (HCO3) from carbon dioxide and water. The sulfonamide derivatives were found to be active against hCA I and II in the range of 2.62–136.54 and 5.74–210.58 nM, respectively.

Acknowledgements

We thank Prof. Ramazan Altundas of Ataturk University for his useful discussions, F. Melike Al of University of Applied Sciences (BeuthHS) for her support for the synthetic studies, Dr. Meryem Topal for carbonic anhydrase inhibition activity studies, Dr. Ilker Un and Muhiddin Cergel for NMR spectrums and Gokhan Bilsel for HRMS spectrums.

Declaration of interest

The authors have declared no conflict of interest.

Supplementary material available online

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.